NASTECH PHARMA ENTWICKELT NEBENWIRKUNGSFREIES KONKURRENZEPRODUKT ZU VIAGRA!!!!

Die Nasdaq stürzt ab, nur Nastech Pharma bleibt konstant, kein Wunder bei der Produkutpalette dieses Unternehmens und angesichts der Tatsache, daß die Aktien fast ausschließlich in der Hand seriöser Langfristanleger sind.

Ihr wollt Zahlen, Daten und Fakten?

Dann schaut Euch mal folgende Links an:

http://biz.yahoo.com/p/n/nstk.html
http://www.performaxx.de/s/magazin/stis0005.htm
http://finance.yahoo.com/q?s=nstk&d=v1
http://biz.yahoo.com/prnews/000509/ny_nastech_1.html
http://biz.yahoo.com/prnews/000511/ny_nastech_1.html

Nastech Completes Pilot In-Clinic Efficacy Studies of Intranasal Apomorphine Indicated for Erectile Dysfunction
- No Significant Side Effects Reported -
HAUPPAUGE, N.Y., April 11 /PRNewswire/ -- Nastech Pharmaceutical Company Inc (Nasdaq: NSTK - news) today announced the completion of its pilot, in-clinic studies that were designed to determine the safety and efficacy of its intranasal apomorphine formulation at various dose levels. The in-clinic dose ranging studies indicate efficacy at various dose levels with no significant side effects reported.

``We are pleased by the results of our in-clinic studies,'' said Charan Behl, Ph.D., Executive Vice President - Research and Development. ``The data gathered, coupled with public information released by TAP Pharmaceutical on its sublingual apomorphine product, Uprima®, provides directional insight as to our planned at-home efficacy studies to be conducted in the near future.''

``We are particularly pleased,'' Dr. Behl noted, ``by the FDA advisory committee's recent announcement that recommended approval of Uprima. This recommendation bodes well for our intranasal apomorphine product and may accelerate our development timeline and reduce the cost of certain studies. In particular, there were no material pre-clinical toxicological or pharmacological issues noted in the briefing document submitted by the FDA to the advisory committee.'' Dr. Behl added that the intranasal dose levels demonstrating high in-clinic efficacy are substantially lower than the lowest dose level (2mg) of Uprima, and patients reported no serious side effects at the dose levels studied.

Nastech Pharmaceutical Company Inc is recognized worldwide as a leader in nasal drug delivery. In addition to intranasal apomorphine for the treatment of sexual dysfunction, the company is developing intranasal scopolamine hydrobromide for the prevention and treatment of motion sickness and intranasal morphine for the treatment of moderate-to-severe-pain. Additional information on Nastech is available at http://www.Nastech.com.

This press release may contain forward-looking statements that reflect the Company's intentions, expectations or beliefs concerning future events, including, but not limited to, expectations with respect to FDA approval of new products, technology and product development milestones, the ability of the Company to leverage its product development and negotiate favorable collaborative agreements, the commencement of sales and the sufficiency of the Company's cash flow for future liquidity and capital resource needs. The forward-looking statements are qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. In addition, significant fluctuations in quarterly results may occur as a result of varying milestone payments and the timing of costs and expenses related to the Company's research and development program.

 

 

1. Ist dies schon seit Anfang April bekannt
2. wird es nur bei psychogenen Erektionproblemen Wirkung zeigen
also keine Spur asl Konkurrenz zu Viagra
3. Zwar sind die Nebenwirkungen geringer, aber auch die Wirkung ist geringer !
4. wird man Uprima nur bei ausgewählten Fällen anwenden können! Also nix für  uns!  

 

Frag mal Deinen Hausarzt. Der wird es Dir bestätigen
Also eröffnet sich ein riesiger Markt  

Glaubst Du, dass wenn man eine Pille schluckt alle Probleme gelöst sind?
Ist eher ein Fall für Psychologen!
Viagra findet vor allem Anwendung bei älteren Herren! Die wollen zwar, können aber nicht! Und das ist nicht psychisch bedingt!

Fazit: Keine grossen Hoffnungen in Uprima!  

Also keine Pille. Außerdem will jeder potentielle Kunde nur das eine. Nur die Ursachen seiner Störung sind unterschiedlich. Und psychische Ursachen überwiegen. Doch der Spray kann mittels Apomorphinen das Sexualzentrum im Gehirn stimmulieren.